We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 20, 2024 – Today, Zacks Investment Ideas feature highlights Virax Biolabs Group (VRAX) , GeoVax Labs (GOVX - Free Report) , Applied DNA Sciences (APDN - Free Report) and Emergent BioSolutions (EBS - Free Report) .
WHO Declares Mpox Public Emergency: 5 Stocks to Watch
The World Health Organization (WHO) is a branch of the United Nations dedicated to health. Founded in 1948, the WHO’s primary roles include supervising and coordinating health programs. The WHO also monitors health trends, establishes guidelines and suggestions, and supports countries that need it. Moreover, the WHO leads efforts to control diseases, improve healthcare systems, and tackle health emergencies and pandemics.
WHO Declares Monkeypox State of Emergency
Health officials at the world’s most-followed health agency are raising the red flag on the Monkeypox virus, labeling it a global health emergency for the second time in two years. A Global Health Emergency, as declared by the World Health Organization (WHO), refers to an extraordinary event that constitutes a public health risk to other countries through the international spread of disease and requires a coordinated global response.
What Is Monkeypox?
Monkeypox is an illness similar to smallpox, although it is usually less severe. It is caused by the monkeypox virus, which belongs to the virus family as smallpox. The symptoms of the illness are similar to those of the flu such as fever and headache followed by a rash that can develop into pus-filled sores.
Typically, Monkeypox is transmitted to humans from animals like rodents and primates; however, it can also spread between individuals through contact with a person and contaminated objects. While outbreaks mainly occur in Central and West Africa, they have also been observed in parts of the world. Though the disease has been rare historically, officials are growing concerned because it is becoming more widespread.
More than 10,000 cases have been reported in Africa, resulting in more than 500 deaths. Officials are now worried that the disease will inevitably spread to other parts of the world.
Monkeypox Stocks to Watch
The COVID-19 pandemic illustrated how impactful a global pandemic can be to the world economy and the stock market. COVID-19 resulted in the worst stock market crash and global recession since the global financial crisis of 2008. While there is no way to predict what the impact of Mpox will be, investors need to prepare a watchlist of monkeypox-related stocks to gauge the action, at the very least.
Mpox Testing Stock: Virax Biolabs Group is up more than 100% today. VRAX manufactures testing kits for Monkeypox.
MPOX Vaccine Makers: GeoVax Labs, Applied DNA Sciences
Mpox Treatment Stock: Emergent BioSolutions
Bottom Line
Is the next pandemic here? With health officials declaring Monkeypox a public health emergency, investors need to be watching monkeypox-related stocks closely.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
For Immediate Release
Chicago, IL – August 20, 2024 – Today, Zacks Investment Ideas feature highlights Virax Biolabs Group (VRAX) , GeoVax Labs (GOVX - Free Report) , Applied DNA Sciences (APDN - Free Report) and Emergent BioSolutions (EBS - Free Report) .
WHO Declares Mpox Public Emergency: 5 Stocks to Watch
The World Health Organization (WHO) is a branch of the United Nations dedicated to health. Founded in 1948, the WHO’s primary roles include supervising and coordinating health programs. The WHO also monitors health trends, establishes guidelines and suggestions, and supports countries that need it. Moreover, the WHO leads efforts to control diseases, improve healthcare systems, and tackle health emergencies and pandemics.
WHO Declares Monkeypox State of Emergency
Health officials at the world’s most-followed health agency are raising the red flag on the Monkeypox virus, labeling it a global health emergency for the second time in two years. A Global Health Emergency, as declared by the World Health Organization (WHO), refers to an extraordinary event that constitutes a public health risk to other countries through the international spread of disease and requires a coordinated global response.
What Is Monkeypox?
Monkeypox is an illness similar to smallpox, although it is usually less severe. It is caused by the monkeypox virus, which belongs to the virus family as smallpox. The symptoms of the illness are similar to those of the flu such as fever and headache followed by a rash that can develop into pus-filled sores.
Typically, Monkeypox is transmitted to humans from animals like rodents and primates; however, it can also spread between individuals through contact with a person and contaminated objects. While outbreaks mainly occur in Central and West Africa, they have also been observed in parts of the world. Though the disease has been rare historically, officials are growing concerned because it is becoming more widespread.
More than 10,000 cases have been reported in Africa, resulting in more than 500 deaths. Officials are now worried that the disease will inevitably spread to other parts of the world.
Monkeypox Stocks to Watch
The COVID-19 pandemic illustrated how impactful a global pandemic can be to the world economy and the stock market. COVID-19 resulted in the worst stock market crash and global recession since the global financial crisis of 2008. While there is no way to predict what the impact of Mpox will be, investors need to prepare a watchlist of monkeypox-related stocks to gauge the action, at the very least.
Mpox Testing Stock: Virax Biolabs Group is up more than 100% today. VRAX manufactures testing kits for Monkeypox.
MPOX Vaccine Makers: GeoVax Labs, Applied DNA Sciences
Mpox Treatment Stock: Emergent BioSolutions
Bottom Line
Is the next pandemic here? With health officials declaring Monkeypox a public health emergency, investors need to be watching monkeypox-related stocks closely.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.